Latest filing published 22 May 2023 for Bellerophon Therapeutics, Inc., €7,113.
Filing timeline
BuySaleInsider track record
Bobae Kim: trading record in brief
Bobae Kim is a declared insider of Bellerophon Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings, every one of them for a trade on 18 May 2023.
No open-market purchase appears, only 1 sale worth €88k. Other entries cover 2 option exercises.
The newest entry dates from 22 May 2023: an option exercise of €7,113, in Bellerophon Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bobae Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,022 shares@ US$7.507.4% of flowCommon StockSEC:0001104659-23-063263:1
- 9,455 shares@ US$10.0090.8% of flowCommon StockSEC:0001104659-23-063263:2
- 266 shares@ US$7.35100.0% of flowCommon StockSEC:0001104659-23-063263:0
3 of 3 declarations